Larger Peristaltic Pumps Allow Scale-Up
Watson-Marlow Fluid Technology Group (WMFTG) has expanded its range of peristaltic cased pumps for upstream and downstream bioprocessing tasks.
Watson-Marlow Fluid Technology Group (WMFTG) has expanded its range of peristaltic cased pumps for upstream and downstream bioprocessing tasks. The existing 120 and 530 models are now joined by 630 and 730 higher flow pumps, allowing research projects or production to be scaled up without changing or impacting the process.
WMFTG’s 120, 530, 630, and 730 process pumps share the same functionality to enhance compliance with cGMP. The expanded range (from 0.000000264 gal/min up to 8.7 gal/min) covers a wide spectrum of bioprocessing tasks and simplifies scaling.
A human machine interface requires minimal key presses to reduce the opportunity for errors. Process security is enhanced with the addition of a 3-level PIN lock. Control options include manual, remote, analogue, and RS485 digital communications, along with integrated PROFIBUS networking capabilities.
The new cased pumps are designed for use with single-use fluid path assemblies, and the low-shear pump action means that product can be moved without degradation or damage.
Watson-Marlow Fluid Technology Group
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
